Natriuretic peptides and primary prevention: The new world?

Journal of the American College of Cardiology

Volumn 62, Issue 15, 2013, Pages 1373-1375

  Felker, G Michael ^a   Ahmad, Tariq ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

beta blocker; diabetes mellitus; NT proBNP selected; primary prevention; RAS antagonists

Indexed keywords

EID: 84885014641     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.06.009     Document Type: Editorial

References (21)

1. Kling A. West DC The Libro de las profecias of Christopher Columbus 1991 University of Florida Press Gainesville, FL
2. J.B. Buse, H.N. Ginsberg, and G.L. Bakris Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association Circulation 115 2007 114 126
3. D.D. Schocken, E.J. Benjamin, and G.C. Fonarow Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation 117 2008 2544 2565
4. T.J. Wang, P. Gona, and M.G. Larson Multiple biomarkers for the prediction of first major cardiovascular events and death N Engl J Med 355 2006 2631 2639
5. D.A. Morrow Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 J Am Coll Cardiol 41 2003 1264 1272
6. S. Talwar Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction Eur Heart J 21 2000 1514 1521
7. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
8. A.S. Maisel, and L.B. Daniels Breathing not properly 10 years later: what we have learned and what we still need to learn J Am Coll Cardiol 60 2012 277 282
9. M. Ledwidge, J. Gallagher, and C. Conlon Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial JAMA 310 2013 66 74
10. M. Huelsmann, S. Neuhold, and M. Resl PONTIAC (NT-proBNP selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease): a prospective randomized controlled trial J Am Coll Cardiol 62 2013 1365 1372
11. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
12. P. Gaede, H. Lund-Andersen, H.H. Parving, and O. Pedersen Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 2008 580 591
13. P.M. Ridker, E. Danielson, and F.A. Fonseca Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
14. Writing Group for the Women's Health Initiative I Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
15. G.M. Felker, V. Hasselblad, A.F. Hernandez, and C.M. O'Connor Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials Am Heart J 158 2009 422 430
16. G. Savarese, B. Trimarco, and S. Dellegrottaglie Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials PloS One 8 2013 e58287
17. R.S. Vasan Biomarkers of cardiovascular disease: molecular basis and practical considerations Circulation 113 2006 2335 2362
18. E. Braunwald Heart failure. J Am Coll Cardiol HF 1 2013 1 20
19. J. Loscalzo Personalized cardiovascular medicine and drug development: time for a new paradigm Circulation 125 2012 638 645
20. A.L. Barabasi, N. Gulbahce, and J. Loscalzo Network medicine: a network-based approach to human disease Nat Rev Genet 12 2011 56 68
21. T.J. Wang, K.C. Wollert, and M.G. Larson Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study Circulation 126 2012 1596 1604